These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 36032027)
1. Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics. Konishi I; Abiko K; Hayashi T; Yamanoi K; Murakami R; Yamaguchi K; Hamanishi J; Baba T; Matsumura N; Mandai M; J Gynecol Oncol; 2022 Sep; 33(5):e83. PubMed ID: 36032027 [TBL] [Abstract][Full Text] [Related]
2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
3. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma]. Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294 [No Abstract] [Full Text] [Related]
4. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma. Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751 [TBL] [Abstract][Full Text] [Related]
7. Specific Mechanisms of Chromosomal Instability Indicate Therapeutic Sensitivities in High-Grade Serous Ovarian Carcinoma. Tamura N; Shaikh N; Muliaditan D; Soliman TN; McGuinness JR; Maniati E; Moralli D; Durin MA; Green CM; Balkwill FR; Wang J; Curtius K; McClelland SE Cancer Res; 2020 Nov; 80(22):4946-4959. PubMed ID: 32998996 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium. Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696 [TBL] [Abstract][Full Text] [Related]
10. The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin. Kessler M; Fotopoulou C; Meyer T Int J Mol Sci; 2013 Mar; 14(4):6571-96. PubMed ID: 23528888 [TBL] [Abstract][Full Text] [Related]
14. Cell Origins of High-Grade Serous Ovarian Cancer. Kim J; Park EY; Kim O; Schilder JM; Coffey DM; Cho CH; Bast RC Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30424539 [TBL] [Abstract][Full Text] [Related]
15. Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum. Ohsuga T; Yamaguchi K; Kido A; Murakami R; Abiko K; Hamanishi J; Kondoh E; Baba T; Konishi I; Matsumura N BMC Cancer; 2017 Aug; 17(1):580. PubMed ID: 28851311 [TBL] [Abstract][Full Text] [Related]
16. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912 [TBL] [Abstract][Full Text] [Related]
17. CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR. Bapat J; Yamamoto TM; Woodruff ER; Qamar L; Mikeska RG; Aird KM; Watson ZL; Brubaker LW; Bitler BG Cancer Gene Ther; 2024 Feb; 31(2):300-310. PubMed ID: 38030811 [TBL] [Abstract][Full Text] [Related]
18. Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer. Dahl ES; Buj R; Leon KE; Newell JM; Imamura Y; Bitler BG; Snyder NW; Aird KM Mol Cancer Res; 2019 Aug; 17(8):1710-1720. PubMed ID: 31110157 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological study of SET subtype of ovarian high-grade serous carcinoma]. Sun YW; Shen DH; Cui SS; He HJ; Zhang XL; Wang W; Liu CR Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):595-600. PubMed ID: 31550775 [No Abstract] [Full Text] [Related]
20. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum]. Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]